View Full Paper

Owner Consent Verified
Research Proposal 4.6

Artificial Intelligence Adoption in Pharmaceutical Firms: Equity And Access — Post-Pandemic Lessons

26
Pages
Harvard
Style
~ 27–40 mins
Reading Time
Health Supply Chain NLP
Abstract

This research proposal investigates “Artificial Intelligence Adoption in Pharmaceutical Firms: Equity And Access — Post-Pandemic Lessons” using a panel regression with fixed effects. Through a behavioral lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.

Download PDF Order Similar Paper Save

Artificial Intelligence Adoption in Pharmaceutical Firms: Equity And Access — Post-Pandemic Lessons

ABSTRACT
Artificial Intelligence Adoption in Pharmaceutical Firms: Equity And Access — Post-Pandemic Lessons is unpacked across themes: KPIs, risks, interoperability, and costs. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
14 Pages 4.8
Green Finance for Gen Z Shoppers: Customer Experience | Post-Pandemic Lessons
Psychology AI InsurTech
View Paper
17 Pages 4.4
UX Research for City Planners: Data Quality And Bias | 2023–2026 Trends
Energy Esports AIOps
View Paper
30 Pages 4.4
Corporate Governance Adoption in EU Startups: Sustainability Outcomes — Evidence from Latin America
Sustainability HCI Cold Chain
View Paper